Direxion Daily LLY Bull 2X Shares

Eli Lilly Completes Key Drug Interaction Study for its KRAS Inhibitor, Olomorasib

New report shows Eli Lilly and Novo Nordisk dominate GLP-1 drug citations in AI tools

Lilly China Launches "Tuo Hu Chang An" Patient Assistance Program to Support IBD Patients

Eli Lilly & UNICEF Launch US$50m Partnership Program for Childhood Chronic Diseases

Lilly Asia Ventures Participates in Accro Bioscience's $50 Million Series C Financing

Institutional Investor Larson Financial Group LLC Reduces Stake in Eli Lilly

Investment firm Gambit Capital Management makes a new $26.54 million investment in Eli Lilly

Japan Approves Eli Lilly's Zepbound for Obstructive Sleep Apnea

Eli Lilly Scales Up AI-Driven Drug R&D and Production with Dell Solutions

Harbour BioMed releases positive preclinical obesity data on its potential rival drug, LET003

Novo Nordisk plans to launch Wegovy oral weight-loss drug outside the US, intensifying competition with Eli Lilly

Eli Lilly announces its RET kinase inhibitor selpercatinib has entered a Phase III clinical trial for the first-line treatment of RET fusion-positive lung cancer

Eli Lilly and other Fortune 500 pharmaceutical giants establish a presence in Beijing International Pharmaceutical Innovation Park

Report claims Trump purchased Eli Lilly stock during period of favorable government policies

Investment firm GLOBALT increases its stake in Eli Lilly and Company

Multiple analyst firms update ratings and earnings forecasts for Eli Lilly

Eli Lilly's Q1 2026 revenue soars 56%, topping global pharmaceutical sales charts

Eli Lilly and Company to Participate in EASD Industry Symposium

Institutional Investors Show Mixed Changes in Eli Lilly Holdings

Eli Lilly Announces Additional $4.5 Billion Investment to Expand US Manufacturing Capacity for Weight-Loss Therapies

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Pinned News

置顶新闻

Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

ELIL

LLYX

Donald Trump disclosed stock purchases of up to $680,000 in Eli Lilly as Medicare initiatives advanced GLP-1 drug coverage. The investments coincided with policies benefiting the drugmaker's obesity treatments. Trump's purchases also included shares in West Pharmaceutical Services, valued between $250,000 and $500,000. A spokesperson stated that his investments are managed independently by third-party institutions. Eli Lilly shares rose 2.73% to $1015.09, gaining 9.4% over the past month.

benzinga_article

Eli Lilly

West Pharmaceutical

iShares US Pharma

Defiance Daily Target 2X Long LLY ETF

Health Care Select Sector SPDR

VG Health

Thomson Reuters

S&P 500

NVDA

Government ethics disclosures reveal Eric Trump made 3,642 stock transactions worth up to $750 million in early 2026, with some trades in Nvidia and Eli Lilly occurring just before favorable administration actions, raising conflict-of-interest concerns. Despite Eric Trump's denial that family members direct trades, lawmakers point to signed disclosures that contradict his statements.

- Government ethics disclosures indicate that Trump made 3,642 stock transactions valued up to $750 million in early 2026, with many involving specific companies.  
- Some trades, particularly in Nvidia and Eli Lilly, happened shortly before government actions that benefited those companies, raising conflict-of-interest concerns.  
- Despite Eric Trump's claims that family members do not direct trades, signed disclosures reveal individual stock purchases that contradict these assertions.

NVIDIA

NVIDIA Corporation

Eric Trump denial challenged by filings showing timed stock buys

ABBV

NVDQ

IBBQ

LABU

In today's trading, U.S. semiconductor stocks like Nvidia and AMD saw significant declines, while the healthcare sector, led by Eli Lilly and AbbVie, showed gains. The market sentiment is cautious due to concerns over the global chip shortage, but optimism in healthcare suggests a shift in investor interest. Recommendations include increasing healthcare allocations and considering semiconductor stocks for risk-tolerant investors, emphasizing the importance of diversification.

- The U.S. stock market showed mixed results, with technology stocks, notably semiconductors like Nvidia and AMD, experiencing declines amid pressures in the industry.  
- In contrast, the healthcare sector thrived with gains from Eli Lilly and AbbVie due to strong earnings and positive clinical news, attracting investor interest.  
- Strategic recommendations suggest investors increase healthcare sector allocations while considering the semiconductor weaknesses as potential buying opportunities for those willing to endure short-term fluctuations.

Investinglive

Abbvie

T-Rex 2X Inverse NVIDIA Daily Target ETF

ALPS Medical Breakthrough

Direxion Daily NVDA Bear 1X ETF

Invesco Nasdaq Biotechnology ETF

Direxion Daily NVDA Bull 2X Shares

iShares Global Healthcare

GraniteShares 2x Long NVDA Daily ETF

First Trust NYSE Arca Biotech Index Fd

Direxion Semicon Bear 3X

Direxion S&P Biotech Bull 3X

Direxion Daily AMD Bear 1X Shares

Direxion Daily AMD Bull 2X Shares

AXS 1.5X NVDA Bear Daily ETF

GraniteShares 2x Long AMD Daily ETF

GraniteShares 2x Short NVDA Daily ETF

Intel

Tech turmoil: Semiconductor stocks slide, healthcare finds footing

President Trump purchased $680,000 in Eli Lilly (LLY) stock around the FDA's approval of a new weight-loss pill. The timing of these trades coincides with favorable government decisions benefiting Lilly, including a Medicare reimbursement pilot program for GLP-1 drugs. Trump's stock trades, disclosed in ethics forms, include various investments across sectors, but Lilly's trades stand out due to their potential impact on the company's revenue growth, projected to exceed $80 billion in 2026.

Tip Ranks

iShares Biotechnology ETF

Microsoft

Boeing

Target

Chipotle Mexican Grill

Citigroup

Toronto Dominion Bank

Boeing Company

CITIGROUP INC 6.250 NON CUM SER II PFD WI

President Trump Bought Eli Lilly Stock (LLY) as Government Approved Weight-Loss Pill

ELIS

The U.S. Supreme Court denied Eli Lilly's petition, finalizing a $220M judgment for defrauding the Medicaid Drug Rebate Program. This marks a significant victory for whistleblower Ronald J. Streck and his legal team after a 12-year legal battle. The case, initiated in 2014, revealed that Eli Lilly failed to pay required Medicaid rebates following price increases. This decision upholds a unanimous jury verdict and highlights the success of False Claims Act litigation.

prnewswire

Direxion Daily LLY Bear 1X Shares

Proshares Ultra Nasdaq Biotech

Ark Genomic Revolution ETF

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

07:27 ETWMHW Secures Victory; U.S. Supreme Court Denies Eli Lilly's Petition for Certiorari, Finalizing $220M+ False Claims Act Judgment

The company is riding an incredible tailwind.

Eli Lilly stock: Next stop $2,000?

Eli Lilly has partnered with Caitlin Clark’s foundation to open three multisport community courts in Indianapolis, including two at public schools and one in a park. This initiative is part of Lilly's 150th anniversary celebrations, with the courts designed for basketball, soccer, and futsal. The project involves Musco Lighting and aims to enhance community access to sports facilities. Lilly's campaign, '150 Years of Everything Else,' promotes its brand through various media.

Fiercepharma

Lilly allies with Caitlin Clark for Indianapolis sports courts

GBTC

SBFM

The stock market opened with significant movements: Sunshine Biopharma (SBFM) surged, while Bitcoin Depot (BTM) plummeted due to bankruptcy. Eli Lilly (LLY) fell after a Supreme Court decision, and SpaceX plans a stock split. Boston Scientific (BSX) announced a share buyback, and Costco (COST) hit a 52-week high. Other notable changes included declines for Meta (META) and Advanced Micro Devices (AMD), while Netflix (NFLX) rose on positive analyst coverage.

- The trading week has begun with significant movements in various stocks, including a massive rally for Sunshine Biopharma (SBFM) and volatility for Redwire (RDW).  
- Notable declines include Bitcoin Depot (BTM) following a bankruptcy filing, while Costco Wholesale (COST) reached a new 52-week high due to a dividend increase.  
- Overall, the Dow Jones (DJIA) experienced a dip amidst rising oil prices and mixed performances across tech and retail sectors.

Meta Platforms

Grayscale Bitcoin Trust BTC - ETF

Sunshine Biopharma

Netflix

Boston Scientific

Costco Wholesale

Bitcoin Depot

CoinShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

iShares Bitcoin Trust ETF

Leverage Shares 2X Long Cost Daily ETF

Roundhill NFLX WeeklyPay ETF

Fidelity Wise Origin Bitcoin Fund - ETF

WisdomTree Bitcoin Fund

ARK 21Shares Bitcoin ETF

T-REX 2X Long NFLX Daily Target ETF

Bitwise Bitcoin ETF

Franklin Bitcoin ETF

Redwire

Lululemon

Salesforce

Hims & Hers Health

Seagate Tech

Dow Jones Industrial Average

Starbucks

Take-Two Interactive Software

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

BITCOIN DEPOT INC C/WTS 30/06/2028(TO PUR COM)

Morning News Wrap-Up, 5/18/26: Today's Biggest Stock Market Stories!

The U.S. Supreme Court has rejected Eli Lilly's appeal regarding a $194 million whistleblower judgment for underpaying Medicaid rebates by misreporting drug pricing. The decision upholds the federal False Claims Act, allowing private individuals to sue on behalf of the government. Eli Lilly's stock fell 1.64% to $988.42 following the ruling, with the company arguing that the whistleblower's claims were unfounded and that its pricing practices were industry-standard.

Fidelity

Defiance Daily Target 2X Short LLY ETF

Ondas

Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

Trump purchased up to $680,000 in Eli Lilly stock amid favorable federal policies for its obesity drugs. Legal ethicists express concerns about the timing potentially undermining public trust, although Trump's team claims the trades are independently managed. This move reflects a broader shift from bonds to numerous stock trades linked to administration policies.

Trump purchased Eli Lilly stock as policies favored its drugs

Today's market shows mixed results across sectors. Tech stocks see volatility with Oracle down 3.60% and Nvidia falling 1.22%, while Google rises 2.28%. The healthcare sector faces pressure, with Eli Lilly down 1.58%. Financials are mixed, with Bank of America up 1.64% but American Express down 0.58%. Investors are advised to diversify portfolios to navigate sector challenges and capitalize on emerging trends.

YieldMax NVDA Option Income Strategy ETF

T-Rex 2X Long NVIDIA Daily Target ETF

Defiance Daily Target 2X Long ORCL ETF

Direxion Daily GOOGL Bull 2X Shares

Roundhill GOOGL WeeklyPay ETF

Oracle

Micron Tech

Alphabet

Alphabet - C

Amazon

CVS Health

Bank of America

Visa

American Express

ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Tech stocks rally while healthcare faces pressure: A closer look at today's market

Direxion Daily LLY Bull 2X Shares(ELIL.US)